Literature DB >> 34140741

Introduction - Validation of tests for OIE-listed diseases as fit-for-purpose in a world of evolving diagnostic technologies.

I A Gardner, A Colling, C Caraguel, J R Crowther, G Jones, S M Firestone, C Heuer.   

Abstract

The World Organisation for Animal Health (OIE) has made leading contributions to the discipline of test validation science by providing standards and guidelines that inform the test validation process in terrestrial and aquatic animals. The OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, and the Manual of Diagnostic Tests for Aquatic Animals describe the test validation pathway in the context of fitness for purpose, elaborate on the importance of diagnostic sensitivity (DSe) and specificity (DSp) as measures of test accuracy, and designate additional factors (e.g. test cost, laboratory throughput capacity and rapidity of test results) that influence choices of a single test over others or the inclusion of a new test in a diagnostic process that includes multiple tests. This paper provides examples of each of the six main testing purposes listed in the Terrestrial Manual and describes additional metrics such as ruggedness and robustness that should be included in the validation of point-of-care tests. Challenges associated with new diagnostic technologies and platforms are described. Validated tests with estimates of DSe and DSp are needed to measure confidence in test results for OIE-listed diseases, to facilitate risk assessments related to animal movement, to estimate true prevalence, and for certification of disease freedom and use in epidemiological (risk factor) studies.

Entities:  

Keywords:  Diagnostic test; Validation; World Organisation for Animal Health

Year:  2021        PMID: 34140741     DOI: 10.20506/rst.40.1.3207

Source DB:  PubMed          Journal:  Rev Sci Tech        ISSN: 0253-1933            Impact factor:   1.181


  1 in total

1.  Non-lethal sampling for the detection of Renibacterium salmoninarum by qPCR for diagnosis of bacterial kidney disease.

Authors:  Eva Jansson; Anna Aspán; Arianna Comin; Maj Hjort; Tomas Jinnerot; Charlotte Axén
Journal:  J Fish Dis       Date:  2022-04-01       Impact factor: 2.580

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.